共 50 条
- [1] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (02):
- [2] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2016, (07):
- [3] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (05):
- [4] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (06):
- [5] Palivizumab for prophylaxis against respiratory syncytial virus infection in children with cystic fibrosis [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2012, (02):
- [6] Palivizumab prophylaxis for respiratory syncytial virus in infants with cystic fibrosis: is there a need? [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1113 - 1118
- [9] Respiratory syncytial virus prophylaxis in cystic fibrosis: the Canadian registry of palivizumab data (2005–2016) [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2018, 37 : 1345 - 1352
- [10] Cost-effectiveness of respiratory syncytial virus prophylaxis with palivizumab [J]. ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (05): : 519 - 520